Abstract
First of Its Kind Treatment – Repatha® (evolocumab) – Available to Address Unmet Needs in Patients with Uncontrolled LDL Cholesterol in Singapore. Agilent Technologies Announces Revolutionary Triple Quadrupole Mass Spectrometer. Bristol-Myers Squibb’s Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen Receives Approval from Singapore’s Health Sciences Authority in Unresectable or Metastatic Melanoma [1]. National Supercomputing Centre Singapore and Global Gene Corp Sign a Strategic Collaboration in Support of Singapore’s Precision Medicine Initiative. Parkway Pantai Introduces New 3-D Mammography Technology in Singapore Developed by GE Healthcare with More Patient Comfort in Mind. Philips and Singapore Institute of Advanced Medicine Holdings Sign Agreement to Open First-of-its-kind Oncology Center in Singapore. Siemens Launches First Fully Integrated Digitalization Hub in Singapore.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
